JP5568461B2 - 血液パラメータをモニタリングするための装置及び方法 - Google Patents
血液パラメータをモニタリングするための装置及び方法 Download PDFInfo
- Publication number
- JP5568461B2 JP5568461B2 JP2010500432A JP2010500432A JP5568461B2 JP 5568461 B2 JP5568461 B2 JP 5568461B2 JP 2010500432 A JP2010500432 A JP 2010500432A JP 2010500432 A JP2010500432 A JP 2010500432A JP 5568461 B2 JP5568461 B2 JP 5568461B2
- Authority
- JP
- Japan
- Prior art keywords
- blood
- body part
- light
- emitter
- reflectance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000004369 blood Anatomy 0.000 title claims description 75
- 239000008280 blood Substances 0.000 title claims description 75
- 238000000034 method Methods 0.000 title claims description 58
- 238000012544 monitoring process Methods 0.000 title description 14
- 238000005259 measurement Methods 0.000 claims description 72
- 238000005534 hematocrit Methods 0.000 claims description 55
- 238000010521 absorption reaction Methods 0.000 claims description 43
- 238000002834 transmittance Methods 0.000 claims description 28
- 230000002829 reductive effect Effects 0.000 claims description 25
- 239000012503 blood component Substances 0.000 claims description 23
- 108010054147 Hemoglobins Proteins 0.000 claims description 18
- 102000001554 Hemoglobins Human genes 0.000 claims description 18
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 15
- 229910052760 oxygen Inorganic materials 0.000 claims description 15
- 239000001301 oxygen Substances 0.000 claims description 15
- INGWEZCOABYORO-UHFFFAOYSA-N 2-(furan-2-yl)-7-methyl-1h-1,8-naphthyridin-4-one Chemical compound N=1C2=NC(C)=CC=C2C(O)=CC=1C1=CC=CO1 INGWEZCOABYORO-UHFFFAOYSA-N 0.000 claims description 14
- 108010064719 Oxyhemoglobins Proteins 0.000 claims description 14
- 108010002255 deoxyhemoglobin Proteins 0.000 claims description 14
- 230000008859 change Effects 0.000 claims description 13
- 210000004204 blood vessel Anatomy 0.000 claims description 9
- 230000003595 spectral effect Effects 0.000 claims description 9
- 210000000624 ear auricle Anatomy 0.000 claims description 3
- 210000000883 ear external Anatomy 0.000 claims description 3
- 210000003371 toe Anatomy 0.000 claims description 3
- 210000003454 tympanic membrane Anatomy 0.000 claims description 3
- 210000001519 tissue Anatomy 0.000 description 49
- 230000009102 absorption Effects 0.000 description 39
- 230000003287 optical effect Effects 0.000 description 23
- 239000000306 component Substances 0.000 description 22
- 210000003743 erythrocyte Anatomy 0.000 description 21
- 238000005516 engineering process Methods 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 238000010586 diagram Methods 0.000 description 9
- 238000002310 reflectometry Methods 0.000 description 9
- 230000006870 function Effects 0.000 description 8
- 230000005540 biological transmission Effects 0.000 description 7
- 208000007502 anemia Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 238000000691 measurement method Methods 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 230000031700 light absorption Effects 0.000 description 3
- 238000006213 oxygenation reaction Methods 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000014767 Myeloproliferative disease Diseases 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000009534 blood test Methods 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000011026 diafiltration Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000001631 haemodialysis Methods 0.000 description 2
- 230000000322 hemodialysis Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000005156 Dehydration Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241001274197 Scatophagus argus Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229960003284 iron Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 238000002106 pulse oximetry Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
- A61B5/14552—Details of sensors specially adapted therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14535—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring haematocrit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6813—Specially adapted to be attached to a specific body part
- A61B5/6825—Hand
- A61B5/6826—Finger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/683—Means for maintaining contact with the body
- A61B5/6838—Clamps or clips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7239—Details of waveform analysis using differentiation including higher order derivatives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Optics & Photonics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Artificial Intelligence (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Physiology (AREA)
- Psychiatry (AREA)
- Signal Processing (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92011607P | 2007-03-27 | 2007-03-27 | |
| US60/920,116 | 2007-03-27 | ||
| PCT/IL2008/000413 WO2008117286A2 (en) | 2007-03-27 | 2008-03-26 | Device and method for monitoring blood parameters |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010522603A JP2010522603A (ja) | 2010-07-08 |
| JP2010522603A5 JP2010522603A5 (enExample) | 2011-05-19 |
| JP5568461B2 true JP5568461B2 (ja) | 2014-08-06 |
Family
ID=39789121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010500432A Expired - Fee Related JP5568461B2 (ja) | 2007-03-27 | 2008-03-26 | 血液パラメータをモニタリングするための装置及び方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US8017407B2 (enExample) |
| EP (1) | EP2129288B1 (enExample) |
| JP (1) | JP5568461B2 (enExample) |
| WO (1) | WO2008117286A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8781546B2 (en) * | 2008-04-11 | 2014-07-15 | Covidien Lp | System and method for differentiating between tissue-specific and systemic causes of changes in oxygen saturation in tissue and organs |
| WO2011068998A2 (en) * | 2009-12-02 | 2011-06-09 | Duke University | Systems and methods for determining hemoglobin concentration utilizing diffuse reflectance at isosbestic wavelengths |
| US9002655B2 (en) | 2010-05-03 | 2015-04-07 | Gambro Lundia Ab | Medical apparatus for extracorporeal blood treatment and method for determining a blood parameter value in a medical apparatus thereof |
| US20130248695A1 (en) * | 2010-10-29 | 2013-09-26 | Duncan MacIntyre | Method and apparatus for analyte detection |
| US20120253149A1 (en) * | 2011-03-30 | 2012-10-04 | Steuer Robert | Method and apparatus for non-invasive photometric blood constituent diagnosis |
| US10092226B2 (en) * | 2011-12-23 | 2018-10-09 | General Electric Company | Method, arrangement, sensor, and computer program product for non-invasively measuring hemoglobin concentrations in blood |
| US20160113530A1 (en) * | 2014-10-23 | 2016-04-28 | Samsung Electronics Co., Ltd. | Method and apparatus for acquiring biological information, and wrist watch-type terminal using the same |
| NZ773842A (en) | 2015-03-16 | 2022-07-01 | Magic Leap Inc | Methods and systems for diagnosing and treating health ailments |
| JP2018534962A (ja) * | 2015-09-23 | 2018-11-29 | コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． | マルチカラーパルスオキシメータ |
| WO2017142399A1 (en) * | 2016-02-16 | 2017-08-24 | Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis | Method, apparatus and software for detection and localization of hidden defects in optically diffuse media |
| CN106940290A (zh) * | 2017-01-22 | 2017-07-11 | 广州地理研究所 | 基于高光谱数据的水库水体氨氮含量估算方法 |
| JP7624218B2 (ja) * | 2018-08-29 | 2025-01-30 | シェバ インパクト リミテッド | 生物組織の酸素化血液量を測定するためのシステムおよび方法 |
| US11744930B2 (en) * | 2020-04-06 | 2023-09-05 | Fresenius Medical Care Holdings, Inc. | Intradialytic monitoring of hemodynamic status based on detection of oxygen signature phase shift |
| WO2022061262A1 (en) * | 2020-09-21 | 2022-03-24 | PAVmed Inc. | Systems and methods for non-invasive solute measurement |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5725217B2 (enExample) * | 1974-10-14 | 1982-05-28 | ||
| US4142101B1 (en) * | 1977-07-20 | 1991-02-19 | Low intensity x-ray and gamma-ray imaging device | |
| US6681128B2 (en) * | 1990-10-06 | 2004-01-20 | Hema Metrics, Inc. | System for noninvasive hematocrit monitoring |
| EP1052930B1 (en) * | 1998-02-05 | 2008-12-10 | Hema Metrics, Inc. | Method and apparatus for non-invasive blood constituent monitoring |
| US6662031B1 (en) * | 1998-05-18 | 2003-12-09 | Abbott Laboratoies | Method and device for the noninvasive determination of hemoglobin and hematocrit |
| JP2000155090A (ja) | 1998-11-20 | 2000-06-06 | Fuji Photo Film Co Ltd | 血管の画像化装置 |
| DE19921928C2 (de) * | 1999-05-12 | 2002-11-14 | Bosch Gmbh Robert | Elektrisches Gerät |
| US6587704B1 (en) * | 1999-06-16 | 2003-07-01 | Orsense Ltd. | Method for non-invasive optical measurements of blood parameters |
| US6213952B1 (en) * | 1999-09-28 | 2001-04-10 | Orsense Ltd. | Optical device for non-invasive measurement of blood related signals utilizing a finger holder |
| US6434408B1 (en) * | 2000-09-29 | 2002-08-13 | Datex-Ohmeda, Inc. | Pulse oximetry method and system with improved motion correction |
| US6505060B1 (en) | 2000-09-29 | 2003-01-07 | Datex-Ohmeda, Inc. | Method and apparatus for determining pulse oximetry differential values |
| US6660995B1 (en) * | 2001-06-25 | 2003-12-09 | Regents Of The University Of California | Particle size analysis in a turbid media with a single-fiber, optical probe while using a visible spectrometer |
| WO2005025399A2 (en) * | 2003-09-12 | 2005-03-24 | Or-Nim Medical Ltd. | Noninvasive optical monitoring of region of interest |
| US7616303B2 (en) * | 2005-04-25 | 2009-11-10 | University Of Massachusetts | Systems and methods for correcting optical reflectance measurements |
-
2008
- 2008-03-26 US US12/593,246 patent/US8017407B2/en not_active Expired - Fee Related
- 2008-03-26 WO PCT/IL2008/000413 patent/WO2008117286A2/en not_active Ceased
- 2008-03-26 JP JP2010500432A patent/JP5568461B2/ja not_active Expired - Fee Related
- 2008-03-26 EP EP08720038.2A patent/EP2129288B1/en not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| EP2129288A4 (en) | 2013-11-06 |
| EP2129288B1 (en) | 2016-12-21 |
| EP2129288A2 (en) | 2009-12-09 |
| US8017407B2 (en) | 2011-09-13 |
| WO2008117286A3 (en) | 2010-02-25 |
| JP2010522603A (ja) | 2010-07-08 |
| US20100076281A1 (en) | 2010-03-25 |
| WO2008117286A2 (en) | 2008-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5568461B2 (ja) | 血液パラメータをモニタリングするための装置及び方法 | |
| JP4176480B2 (ja) | 非侵襲性のヘマトクリット測定値の精度を改善するための方法および装置 | |
| US12076116B2 (en) | Sensor for tissue measurements | |
| JP4465271B2 (ja) | 対象組織内の血液酸素飽和度を非侵襲的に決定する装置 | |
| JP3625475B2 (ja) | 非侵入的にヘマトクリット値をモニタするシステム | |
| JP6596430B2 (ja) | 近赤外分光法および拡散相関分光法のデバイスおよび方法 | |
| US9591999B2 (en) | Determination of tissue oxygenation in vivo | |
| EP2503935B1 (en) | Apparatus for spectrophotometric blood oxygenation monitoring of organs in the body | |
| JP4903980B2 (ja) | パルスオキシメータ及びその操作方法 | |
| US6421549B1 (en) | Adaptive calibration pulsed oximetry method and device | |
| Paul et al. | Design and development of non invasive glucose measurement system | |
| US10925525B2 (en) | Combined pulse oximetry and diffusing wave spectroscopy system and control method therefor | |
| US20080004513A1 (en) | VCSEL Tissue Spectrometer | |
| US20150217056A1 (en) | Therapy systems and methods utilizing tissue oxygenation detection | |
| CN103735274B (zh) | 一种局部脑组织血氧血容绝对量检测装置及检测方法 | |
| US10342488B2 (en) | Probes and pressure modulation algorithms for reducing extratissue contamination in hemodynamic measurement | |
| JP2007509718A (ja) | 体液および電解質障害をモニタリングするデバイスおよび方法 | |
| JPH11244267A (ja) | 血中成分濃度測定装置 | |
| JP2015506197A (ja) | 血液中のヘモグロビン濃度を非侵襲的に測定するための方法、集成装置、センサ、及びコンピュータ・プログラム製品 | |
| Reuss et al. | The pulse in reflectance pulse oximetry: modeling and experimental studies | |
| McMurdy et al. | Photonics‐based In Vivo total hemoglobin monitoring and clinical relevance | |
| Patil et al. | Methods and devices to determine hemoglobin non invasively: A review | |
| Kraitl et al. | Optical non-invasive methods for characterization of the human health status | |
| Kraitl et al. | Analysis of time series for non-invasive characterization of blood components and circulation patterns | |
| IL201199A (en) | A method for controlling blood parameters |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110325 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110325 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20120921 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121005 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20121226 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130108 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130204 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130212 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130226 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130305 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130403 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20130730 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130906 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140606 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140623 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5568461 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| LAPS | Cancellation because of no payment of annual fees |